275 related articles for article (PubMed ID: 23048112)
1. Median approval times for class III medical devices have been well above statutory deadlines set for FDA and CMS.
Zinn AM; Allen JC; Hacker CS
Health Aff (Millwood); 2012 Oct; 31(10):2304-13. PubMed ID: 23048112
[TBL] [Abstract][Full Text] [Related]
2. Medical devices; exemptions from premarket notification and reserved devices; class I--FDA. Notice.
Fed Regist; 1998 Feb; 63(21):5387-93. PubMed ID: 10177333
[TBL] [Abstract][Full Text] [Related]
3. Medical devices; exemption from premarket notification and reserved devices; class I. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Jan; 65(10):2296-323. PubMed ID: 11010655
[TBL] [Abstract][Full Text] [Related]
4. Medical devices; exemption from premarket notification and reserved devices; Class I--FDA. Proposed rule.
Fed Regist; 1998 Nov; 63(218):63222-53. PubMed ID: 10187398
[TBL] [Abstract][Full Text] [Related]
5. Medical devices; retention in class III and effective date of requirement for premarket approval for three preamendments class III devices--FDA. Proposed rule; opportunity to request a change in classification.
Fed Regist; 1998 Jul; 63(146):40673-7. PubMed ID: 10181520
[TBL] [Abstract][Full Text] [Related]
6. Medicare covers the majority of FDA-approved devices and Part B drugs, but restrictions and discrepancies remain.
Chambers JD; May KE; Neumann PJ
Health Aff (Millwood); 2013 Jun; 32(6):1109-15. PubMed ID: 23733986
[TBL] [Abstract][Full Text] [Related]
7. Medical devices; exemptions from premarket notification; class II devices--FDA, Final rule.
Fed Regist; 1998 Nov; 63(212):59222-31. PubMed ID: 10187384
[TBL] [Abstract][Full Text] [Related]
8. Orthopedic devices: classification and reclassification of pedicle screw spinal systems--FDA. Final rule.
Fed Regist; 1998 Jul; 63(143):40025-41. PubMed ID: 10181517
[TBL] [Abstract][Full Text] [Related]
9. Medical devices; exemption from premarket notification requirements; class I devices; technical amendment. Final rule; technical amendment.
Food and Drug Administration. HHS
Fed Regist; 2001 Jul; 66(143):38786-819. PubMed ID: 11725800
[TBL] [Abstract][Full Text] [Related]
10. Medical devices; exemptions from premarket notification; class II devices; vascular tunnelers. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Mar; 65(43):11466-7. PubMed ID: 11010650
[TBL] [Abstract][Full Text] [Related]
11. CMS national coverage determinations for devices.
Brock JA; Jensen TS; Jacques LB
Health Aff (Millwood); 2013 Jan; 32(1):192. PubMed ID: 23297286
[No Abstract] [Full Text] [Related]
12. Gastroenterology and urology devices; effective date of requirement for premarket approval of the implanted mechanical/hydraulic urinary continence device. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Sep; 65(187):57726-32. PubMed ID: 11503643
[TBL] [Abstract][Full Text] [Related]
13. Medical devices; reclassification and codification of suction lipoplasty system for aesthetic body contouring--FDA. Final rule.
Fed Regist; 1998 Feb; 63(31):7703-5. PubMed ID: 10177951
[TBL] [Abstract][Full Text] [Related]
14. Medical devices; device tracking; new orders to manufacturers--FDA. Notice.
Fed Regist; 1998 Mar; 63(42):10638-40. PubMed ID: 10177504
[TBL] [Abstract][Full Text] [Related]
15. Medical devices; 30-day notices and 135-day PMA supplement review--FDA. Direct final rule; withdrawal.
Fed Regist; 1998 Aug; 63(154):42699. PubMed ID: 10182563
[TBL] [Abstract][Full Text] [Related]
16. Medical devices; effective date of requirement for premarket approval for three class III preamendments physical medicine devices--FDA. Proposed rule; opportunity to request a change in classification.
Fed Regist; 1998 Jul; 63(146):40677-81. PubMed ID: 10181521
[TBL] [Abstract][Full Text] [Related]
17. Medical devices; gastroenterology-urology devices; nonimplanted, peripheral electrical continence device. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Apr; 65(68):18236-7. PubMed ID: 11010624
[TBL] [Abstract][Full Text] [Related]
18. Medical devices; implementation of third party review under the Food and Drug Administration Modernization Act of 1997; emergency processing request under OMB review--FDA. Notice.
Fed Regist; 1998 May; 63(99):28388-91. PubMed ID: 10179874
[TBL] [Abstract][Full Text] [Related]
19. Using the MADIT II criteria for implantable cardioverter defibrillators-what is the role of the Food and Drug Administration approval?
Barold HS
Card Electrophysiol Rev; 2003 Dec; 7(4):443-6. PubMed ID: 15071272
[TBL] [Abstract][Full Text] [Related]
20. New obstacles in the path of marketing new medical devices.
Bucci VA; Reiss JB; Hall NC
J Health Care Technol; 1985; 2(2):81-96. PubMed ID: 10300491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
